Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Clinical trial NCT01579929 · COMPLETED
Trial details
- NCT number
- NCT01579929
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2017-08-11
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.